SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-061067
Filing Date
2018-11-20
Accepted
2018-11-20 17:07:22
Documents
3
Period of Report
2018-11-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv507675_8k.htm 8-K 23318
2 EXHIBIT 99.1 tv507675_ex99-1.htm EX-99.1 13354
3 GRAPHIC image_001.jpg GRAPHIC 4466
  Complete submission text file 0001144204-18-061067.txt   44209
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 181196193
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1